Post-streptococcal glomerulonephritis primary prevention: Difference between revisions
| Line 24: | Line 24: | ||
**Better housing | **Better housing | ||
**Prevent overcrowding | **Prevent overcrowding | ||
*A 26-valent vaccine is recommended for children to prevent post-streptococcal glomerulonephritis. | *A 26-valent vaccine is recommended for children to prevent post-streptococcal glomerulonephritis.<ref name="pmid16002631">{{cite journal |vauthors=Dale JB, Penfound T, Chiang EY, Long V, Shulman ST, Beall B |title=Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes |journal=Clin. Diagn. Lab. Immunol. |volume=12 |issue=7 |pages=833–6 |date=July 2005 |pmid=16002631 |pmc=1182208 |doi=10.1128/CDLI.12.7.833-836.2005 |url=}}</ref> | ||
==References== | ==References== | ||
Revision as of 14:33, 17 May 2018
|
Post-streptococcal glomerulonephritis Microchapters |
|
Differentiating Post-streptococcal glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Post-streptococcal glomerulonephritis primary prevention On the Web |
|
American Roentgen Ray Society Images of Post-streptococcal glomerulonephritis primary prevention |
|
FDA on Post-streptococcal glomerulonephritis primary prevention |
|
CDC on Post-streptococcal glomerulonephritis primary prevention |
|
Post-streptococcal glomerulonephritis primary prevention in the news |
|
Blogs on Post-streptococcal glomerulonephritis primary prevention |
|
Directions to Hospitals Treating Post-streptococcal glomerulonephritis |
|
Risk calculators and risk factors for Post-streptococcal glomerulonephritis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
Overview
There are no established measures for the primary prevention of [disease name].
OR
There are no available vaccines against [disease name].
OR
Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
OR
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].
Primary Prevention
- Effective measures for the primary prevention of post-streptococcal glomerulonephritis include:
- Improve hygiene
- Better housing
- Prevent overcrowding
- A 26-valent vaccine is recommended for children to prevent post-streptococcal glomerulonephritis.[1]
References
- ↑ Dale JB, Penfound T, Chiang EY, Long V, Shulman ST, Beall B (July 2005). "Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes". Clin. Diagn. Lab. Immunol. 12 (7): 833–6. doi:10.1128/CDLI.12.7.833-836.2005. PMC 1182208. PMID 16002631.